Qiagen Non-GAAP EPS of $0.60 in-line, revenue of $534M beats by $9.98M
Source: SeekingAlpha
2025-08-05 17:44:05 ET
More on Qiagen
- Qiagen Beats Earnings, But Its Expensive Valuation Caps Upside Potential
- Qiagen N.V. (QGEN) Q1 2025 Earnings Call Transcript
- Qiagen N.V. 2025 Q1 - Results - Earnings Call Presentation
- Qiagen Q2 2025 Earnings Preview
- Qiagen and Gencurix partner for oncology tests
Read the full article on Seeking Alpha
For further details see:
Qiagen Non-GAAP EPS of $0.60 in-line, revenue of $534M beats by $9.98M
Qiagen N.V.
NASDAQ: QGEN
QGEN Trading
1.58% G/L:
$41.16 Last:
892,000 Volume:
$41.83 Open:
QGEN Latest News
March 10, 2026 05:05:00 pm
QIAGEN Receives U.S. Clearance for Gastrointestinal Panels on Fully Automated QIAstat-Dx Rise Syndromic Testing System
QGEN Stock Data
$10,633,318,293
203,932,295
N/A
22
N/A
Biotechnology & Life Sciences
Healthcare
NL
Venlo
